Back to AVTX
Affinity Asset Advisors, LLC → AVTX
Affinity Asset Advisors, LLC AVTX Position History
Avalo Therapeutics, Inc. • Healthcare
Quarters held
4
Latest value
$49.7M
Q3 2026
Peak value
$53.6M
First seen
Q4 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q4 2025 | $19.1M |
| Q1 2026 | $20M |
| Q2 2026 | $53.6M |
| Q3 2026 | $49.7M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $49.7M | 3.24M | — | — |
| Q2 2026 | $53.6M | 2.90M | — | — |
| Q1 2026 | $20M | 1.34M | — | — |
| Q4 2025 | $19.1M | 1.05M | — | — |
Other funds holding AVTX
$66.7M
$64.2M
$59M
$58.5M
$55.3M
$53.4M